1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Randy Windreich: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS Reduced-Intensity Conditioning Regimen, Myeloablative Conditioning Regimen - Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Completed | Randy Windreich | 21 | 2015-09-04 | 2024-07-16 |
Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1)
Alemtuzumab (1) · Busulfan (1) · Hydroxyurea (1) · Melphalan (1) · Thiotepa (1) · fludarabine phosphate (1)
United States (1)